Literature DB >> 25114462

The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.

Praveen S Rathod1, P N Shakuntala1, V R Pallavi1, Rajashekar Kundaragi1, B Shankaranand2, C R Vijay3, K Uma Devi1, Uttam D Bafna1.   

Abstract

There is a continuous debate about the extent and prognostic value of retroperitoneal lymphadenectomy in endometrial cancer. Systematic pelvic and para-aortic lymphadenectomy in endometrial cancer provides a more accurate assessment of neoplastic spread and may help in better individualization of patients for adjuvant therapy. To evaluate the risk and pattern of retroperitoneal lymph nodes metastasis in patients with endometrial cancers having intermediate and high risk factors for nodal metastasis and recurrence. We conducted a prospective nonrandomized study of 62 cases of high risk endometrial cancers examined and treated at our regional cancer institute between the years 2008 and 2012. The inclusion criteria: The intermediate risk; all patients having grade 3 or undifferentiated adenocarcinomas with less than half MI and the grade 1, 2 tumors having more than half MI with tumor size >2 cm. The high risk group; all the patients having grade 3 or undifferentiated adenocarcinomas with more than half MI, the grade 1, 2 tumors with lymph vascular space invasion (LVSI) or cervical stromal invasion as depicted by pre-operative MRI. The type 2 histology uterine papillary serous, clear cell and squamous cell carcinomas. The patients staging was carried out according to the classification established by the FIGO for endometrial cancer in 2009. The Chi-square test was used to analyze the correlation between tumor grade, myometrial invasion, size of the lesion and lymph nodes metastasis and Fisher's correction done whenever the frequency distribution was less than five. The patients mean age was 58.3 (range 31 to 76 years). A total of 118 endometrial cancer patients were treated during the study period. The 56 (47.5 %) patients belonged to low risk and 62 (52.5 %) patients belonged to high risk endometrial cancers. The 52 of 62 cases were eligible for the analysis. The 10 patients' were excluded from further analysis as the post operative specimens final histopathologic examinations in nine cases revealed carcinosarcoma uterus and one case with yolk sac tumor of endometrium. The total 17(32.7 %) of 52 cases had retroperitoneal nodes metastasis; nine of 17 (52.9 %) in this group had both pelvic and para-aortic lymph nodal metastasis and one of 17 (5.9 %) had isolated para-aortic lymph nodal metastasis. The high grade tumors (grade 3) revealed 41.4 % pelvic and 20.7 % para-aortic lymph nodes metastasis and there was statistically significant higher nodal metastasis in both pelvic and para-aortic lymph nodes with increasing depth of myometrial invasion (P = 0.0119 and P = 0.0001) and increasing size of the lesion. (P = 0.04 and P = 0.0501). The intermediate and high risk endometrial cancer is associated with greater degree of lymph node metastasis. A complete surgical staging which involves extrafascial hysterectomy or a type 3 radical hysterectomy when there is a cervical involvement, along with bilateral salphingo-oophorectomy, pelvic, para-aortic lymphadenectomy and an omentectomy when indicated as in the present study, is a valuable modality of treatment in intermediate and high risk cases of endometrial cancers for determining the prognosis and appropriate categorization of these women for adjuvant therapy. It is also possible to achieve a complete surgical staging in these groups of women with acceptable morbidity when performed by a trained gynaecologic oncologist.

Entities:  

Keywords:  Endometrial cancer; Intermediate and high risk; Retroperitoneal lymph nodal metastasis

Year:  2014        PMID: 25114462      PMCID: PMC4116541          DOI: 10.1007/s13193-014-0303-x

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  20 in total

1.  Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer.

Authors:  H Nomura; D Aoki; N Suzuki; N Susumu; A Suzuki; Y Tamada; F Kataoka; A Higashiguchi; S Ezawa; S Nozawa
Journal:  Int J Gynecol Cancer       Date:  2006 Mar-Apr       Impact factor: 3.437

2.  Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.

Authors:  Suk-Joon Chang; Woo Young Kim; Jong-Hyuck Yoon; Seung-Chul Yoo; Ki-Hong Chang; Hee-Sug Ryu
Journal:  Acta Obstet Gynecol Scand       Date:  2008       Impact factor: 3.636

3.  Risk factors and recurrent patterns in Stage I endometrial cancer.

Authors:  P J DiSaia; W T Creasman; R C Boronow; J A Blessing
Journal:  Am J Obstet Gynecol       Date:  1985-04-15       Impact factor: 8.661

4.  Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique.

Authors:  Denis Querleu; François Planchamp; Fabrice Narducci; Philippe Morice; Florence Joly; Catherine Genestie; Christine Haie-Meder; Laurence Thomas; Nathalie Quénel-Tueux; Emile Daraï; Pierre-Hervé Dorangeon; Henri Marret; Sophie Taïeb; Valérie Mazeau-Woynar
Journal:  Int J Gynecol Cancer       Date:  2011-07       Impact factor: 3.437

5.  Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis.

Authors:  J C Schink; J R Lurain; C B Wallemark; J S Chmiel
Journal:  Obstet Gynecol       Date:  1987-08       Impact factor: 7.661

6.  Sentinel lymph node detection in patients with endometrial cancer.

Authors:  Hitoshi Niikura; Chikako Okamura; Hiroki Utsunomiya; Kosuke Yoshinaga; Junichi Akahira; Kiyoshi Ito; Nobuo Yaegashi
Journal:  Gynecol Oncol       Date:  2004-02       Impact factor: 5.482

7.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

Authors:  C P Morrow; B N Bundy; R J Kurman; W T Creasman; P Heller; H D Homesley; J E Graham
Journal:  Gynecol Oncol       Date:  1991-01       Impact factor: 5.482

8.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Authors:  Pierluigi Benedetti Panici; Stefano Basile; Francesco Maneschi; Andrea Alberto Lissoni; Mauro Signorelli; Giovanni Scambia; Roberto Angioli; Saverio Tateo; Giorgia Mangili; Dionyssios Katsaros; Gaetano Garozzo; Elio Campagnutta; Nicoletta Donadello; Stefano Greggi; Mauro Melpignano; Francesco Raspagliesi; Nicola Ragni; Gennaro Cormio; Roberto Grassi; Massimo Franchi; Diana Giannarelli; Roldano Fossati; Valter Torri; Mariangela Amoroso; Clara Crocè; Costantino Mangioni
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

9.  Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

Authors:  Andrea Mariani; Sean C Dowdy; William A Cliby; Bobbie S Gostout; Monica B Jones; Timothy O Wilson; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2008-03-04       Impact factor: 5.482

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

View more
  4 in total

1.  Association of Tumor Size With Myometrial Invasion, Lymphovascular Space Invasion, Lymph Node Metastasis, and Recurrence in Endometrial Cancer: A Meta-Analysis of 40 Studies With 53,276 Patients.

Authors:  Xiaoying Jin; Chunjuan Shen; Xiaodi Yang; Yayuan Yu; Jianzhang Wang; Xuan Che
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

Review 2.  Usefulness of DWI in preoperative assessment of deep myometrial invasion in patients with endometrial carcinoma: a systematic review and meta-analysis.

Authors:  Sushant K Das; Xiang K Niu; Jing L Wang; Li C Zeng; Wen X Wang; Anup Bhetuwal; Han F Yang
Journal:  Cancer Imaging       Date:  2014-11-12       Impact factor: 3.909

Review 3.  Gynecological cancers: A summary of published Indian data.

Authors:  Amita Maheshwari; Neha Kumar; Umesh Mahantshetty
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep

4.  Diagnostic performance of intraoperative assessment in grade 2 endometrioid endometrial carcinoma.

Authors:  Antonio Bandala-Jacques; David Cantú-de-León; Delia Pérez-Montiel; Rosa A Salcedo-Hernández; Diddier Prada; Aarón González-Enciso; Arely Gonzalez-Valdés; Salim Abraham Barquet-Muñoz
Journal:  World J Surg Oncol       Date:  2020-10-30       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.